home / stock / ango / ango news


ANGO News and Press, AngioDynamics Inc. From 03/07/20

Stock Information

Company Name: AngioDynamics Inc.
Stock Symbol: ANGO
Market: NASDAQ
Website: angiodynamics.com

Menu

ANGO ANGO Quote ANGO Short ANGO News ANGO Articles ANGO Message Board
Get ANGO Alerts

News, Short Squeeze, Breakout and More Instantly...

ANGO - Stocks To Watch: Fading The Fear

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

ANGO - AngioDynamics to Present at Two Investor Conferences in March

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March: Conference: Barclays Global Hea...

ANGO - AngioDynamics (ANGO) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by AngioDynamics, Inc. in conjunction with this Read more ...

ANGO - AngioDynamics launches observational study of atherectomy laser

Aimed at differentiating its device from competitors, AngioDynamics ( ANGO +1.5% ) launches PATHFINDER I : Post-Market Registry, a prospective, non-randomized, single-arm observational study evaluating the performance of its Auryon Atherectomy System (an Nd:YAG laser) for the treatment ...

ANGO - AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON(TM) Atherectomy System

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER I-Registry, EX-PAD-05), a pilot study to ev...

ANGO - AngioDynamics (ANGO) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. AngioDynamics   (NASDAQ: ANGO) Q2 2020 Earnings Call Jan 07, 2020 , 8:00 a.m. ET Operator Continue reading

ANGO - AngioDynamics, Inc. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2020 Q2 earnings Read more ...

ANGO - AngioDynamics, Inc. (ANGO) CEO Jim Clemmer on Q2 2020 Results - Earnings Call Transcript

AngioDynamics, Inc. (ANGO) Q2 2020 Earnings Conference Call January 7, 2020 08:00 AM ET Company Participants Jim Clemmer - President and CEO Steve Trowbridge - General Counsel and Interim CFO Conference Call Participants Jason Mills - Canaccord Genuity Matthew Mishan - KeyB...

ANGO - Stock Futures Flat as Investors Weigh Geopolitical Risk

U.S. stock index futures indicated a flat open on Tuesday as Wall Street assessed the growing geopolitical risks stemming from U.S.-Iran tensions. Futures for the Dow Jones Industrials gained 15 points, or 0.1%, Tuesday to 28,657. Futures for the S&P 500 added 1.75 points, or 0.1%...

ANGO - AngioDynamics net loss improves in fiscal Q2

AngioDynamics ( ANGO ) Q2 results : Revenues: $70M (unch). More news on: AngioDynamics, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...

Previous 10 Next 10